Source: Photo.com
May 15, #广东省人类精子库#相关话题登上社交平台热搜第一.
It is understood that the Guangdong Provincial Human Sperm Bank is the third human sperm bank in the country, and the Guangdong Provincial Human Sperm Bank is affiliated to the Guangdong Provincial Reproductive Hospital, which is the only human sperm bank in Guangdong Province approved by the former Ministry of Health in 2003, and is also the third human sperm bank in the country.
According to reports, the service objects of the human sperm bank are mainly two types of people: one is sperm donation volunteers who are willing to donate sperm; The second is healthy people who preserve sperm for themselves, patients before tumor treatment, or infertility patients.
"I don't want to get married, but I want to have a baby, can I apply for sperm from the human sperm bank?" Recently, some single women want to borrow sperm from sperm banks to "give birth out of wedlock".
At present, according to the current laws and regulations of the mainland, assisted reproductive technology is only carried out for legal couples. Therefore, unmarried women cannot apply to use human sperm banks to donate semen to conceive and have children at this stage.
In this regard, Zhang Xinzong, director of the Guangdong Provincial Human Sperm Bank, said that the original intention of setting up a sperm bank in the mainland to carry out sperm donation was to help couples suffering from infertility. The opening of sperm banks to unmarried single women and the increase in the number of users may increase the hidden danger of consanguineous marriage to a certain extent, causing some social problems. In addition, this provision is also related to the existing family concept in the mainland and the difficulties that single-parent families may face in raising children.
Classification of assisted reproductive technologies
辅助生殖技术是人类辅助生殖技术(Assisted Reproductive Technology，ART)的简称，指运用医学技术和方法对配子(精子和卵子)、合子(受精卵)、胚胎进行人工操作，以达到受孕目的技术。 其主要技术可以分为人工授精(Artificial Insemination，AI)和体外受精(In Vitro Fertilization，IVF)及其各种衍生技术。
At present, assisted reproduction services in the mainland market are mainly composed of the following different programs: artificial insemination, gamete transplantation and IVF. Artificial insemination can be further divided into artificial insemination (AIH) and artificial insemination by donor sperm (AID); Gamete transplantation mainly includes gamete fallopian tube transplantation (GIFT) and intrauterine gamete transplantation (GIUT); IVF is divided into three generations, and each generation is suitable for different patients.
Guangdong Province leads the country in the number of assisted reproduction institutions
Under the dual factors of the promotion of the national population policy and the increase in the demand for infertility patients, the number of assisted reproductive institutions has grown rapidly. As of December 31, 2020, there were 536 medical institutions approved to carry out human assisted reproduction, and Guangdong Province had a total of 56, leading the country in the number of assisted reproductive institutions.
From the perspective of the regional distribution of assisted reproductive institutions in Guangdong Province, assisted reproductive institutions are mainly concentrated in economically developed cities, and as of December 31, 2021, the number of assisted reproductive institutions in Shenzhen is far ahead, with a total of 8; It is followed by Dongguan and Guangzhou, with 6 and 5 assisted reproductive institutions, respectively.
Note: The above data do not include the affiliated hospitals of the Ministry (Province) in Guangzhou Medical Colleges and Affiliated Hospitals and units directly under the Committee.
In 2027, the market size of China's assisted reproduction industry is expected to exceed 85 billion yuan
According to the Frost & Sullivan data report, from 2018 to 2023, the compound annual growth rate of China's assisted reproductive services industry is expected to reach 14.5%. With the continuous increase in the infertility rate in the mainland, the increasing penetration rate of assisted reproductive services year by year, and the promotion of the national three-child birth policy, it is expected to maintain a compound annual growth rate of 14.5% from 2023 to 2027, and the market size of assisted reproductive services is expected to be about 85.2 billion yuan in 2027.
"Assisted reproductive technology is not a panacea and cannot solve all fertility problems." Zhang Songying, member of the Standing Committee of the Reproductive Medicine Branch of the Chinese Medical Association and vice president of Sir Run Run Shaw Hospital affiliated to the School of Medicine of Zhejiang University, reminded that many infertility patients become pregnant naturally through simple treatment such as psychological counseling, follicle monitoring or ovulation induction, or surgery for benign gynecological diseases. Only patients who are unable to conceive despite the above treatments should be considered for assisted reproductive technology treatment.
Prospective Economist APP Information Group
For more research and analysis of this industry, please refer to the "Analysis Report on the Development Prospects and Investment Strategic Planning of China's Assisted Reproduction Industry" by the Prospective Industry Research Institute.
At the same time, the Prospective Industry Research Institute also provides solutions such as industrial big data, industrial research reports, industrial planning, park planning, industrial investment, industrial mapping, smart investment promotion system, industry status certificate, IPO consulting/fundraising and investment feasibility study, and specialized and special new small giant declaration. To quote the content of this article in any public information disclosure such as prospectus and annual report, formal authorization from Qianzhan Industry Research Institute is required.
More in-depth industry analysis is available in the [Prospective Economist APP], and you can also communicate and interact with 500+ economists/senior industry researchers. More enterprise data, enterprise information, and enterprise development are all in the [Qichamao APP], the most cost-effective and most comprehensive enterprise query platform.